SpaceX at $135: Why You Should Buy SpaceX Ahead of the Planned Starship “Explosion”
Prediction markets expect SpaceX's next Starship test to end in a fireball, retail investors are fleeing, and the stock has…
Prediction markets expect SpaceX's next Starship test to end in a fireball, retail investors are fleeing, and the stock has…
A seasoned portfolio analyst argues that buy-and-hold investors face a threat more insidious than a sudden crash, and the quiet…
Most retirees treat their 401(k) and Social Security as a pair of levers to pull together, but a growing number…
Nuclear stocks looked unstoppable just weeks ago, but a brutal month-long selloff has split the sector into two very different…
Ripple keeps stacking licenses, bank deals, and regulatory wins, yet the XRP price barely moves. Here is what it would…
Waiting until 70 to claim Social Security locks in a guaranteed 8% annual credit, but the same decision quietly inflates…
Medicare charges higher-income retirees the same coverage at a dramatically higher price, and the rules for who gets hit follow…
Nebius just unveiled an asset-light pivot designed to outmaneuver CoreWeave and the miner-to-AI crowd, yet the stock is cratering anyway.…
More than 80% of the AI infrastructure buildout projected through 2028 has yet to happen, and three ETFs are quietly…
Every time Amazon dips, one investor keeps adding shares while Wall Street fixates on a capex blowout that obscures something…
Social Security's trust funds are burning through reserves faster than most retirees realize, and the window for Congress to act…
That first Social Security check is supposed to feel like a reward, so discovering it falls short of what you…
IREN stock has shed 41% in a single month alongside every major miner-turned-AI-infrastructure name, but a $3.4 billion NVIDIA contract…
A common story with an uncommon answer Picture a woman who just turned 70. She still works an hourly job,…
Bank of America just flagged a hidden revenue engine inside Nvidia that the market is still ignoring, and the numbers…
BNY Mellon and State Street both posted record quarters, but their strategies are moving in opposite directions and only one…
Eli Lilly just wrote a $2.8 billion check on a psychedelic nasal spray that won't have pivotal trial data until…
Few things ruin a Saturday morning faster than the words “your timing chain is going.” Car repair bills arrive unannounced,…
Arm shares have shed nearly a third of their value since mid-June, and investors now face a fork in the…
Coca-Cola shares are up 22% this year and the stock keeps setting new highs, yet Wall Street's consensus target barely…